Symptoms, Timelines, and Look-Alikes
At a Glance
DEND syndrome usually begins with neonatal diabetes, while seizures, low muscle tone, and developmental delay may appear later or be subtle. Classic DEND is more severe than iDEND, and comprehensive genetic testing helps distinguish it from other causes of neonatal diabetes.
Navigating a diagnosis of DEND or iDEND means learning to watch for symptoms that may not all appear at the same time. While diabetes is usually the first recognized sign, other features of the syndrome often emerge gradually. Understanding these possibilities can help you stay proactive, but it is important to remember that the absence of a feature does not rule out the condition.
The Variable Presentation of Symptoms
Symptoms of DEND syndrome often appear in stages, but this timeline is not absolute. Neurological manifestations can be recognized very early, may be subtle, or may become apparent only as the child develops [1].
1. The Neonatal Period (Birth to 6 Months)
The most common initial sign is neonatal diabetes. This can appear as early as the first few days of life, and is frequently diagnosed within the first month [2][3]. You might notice high blood sugar readings, excessive thirst, very frequent diaper changes, irritability, or difficulty gaining weight.
2. Early Infancy and Neurological Signs
Neurological symptoms may begin to appear during infancy. In some children, epilepsy (seizures) is noticed at the same time the diabetes is diagnosed [4]. Importantly, these seizures may not always look like obvious convulsions. They can sometimes be subtle, such as repetitive movements or brief “staring spells.” Action step: If you see staring or unusual repetitive movements, record a video if it is safe to do so, and seek clinical assessment rather than diagnosing epilepsy on your own.
3. Developmental Markers
Developmental delay usually becomes clearer as the child misses expected milestones, such as holding their head up, making eye contact, or later, sitting and crawling [4][5]. Hypotonia, or low muscle tone (sometimes described as feeling “floppy”), is also a common early finding that can precede other delays [6].
DEND vs. iDEND: What’s the Difference?
Doctors use two different terms to describe the syndrome’s severity, though they exist on a spectrum [7].
- Classic DEND: This is the more severe form. It includes the full triad: neonatal diabetes, significant developmental delays, and epilepsy [7][5].
- Intermediate DEND (iDEND): This is considered a milder version. Children with iDEND have neonatal diabetes and may have developmental or coordination challenges that are less severe than in classic DEND [8]. While iDEND is often described as being “without epilepsy,” some individuals with iDEND-associated mutations may still experience seizures or other brain-related activity [9][10].
Look-Alike Conditions
Because many different genetic changes can cause high blood sugar in a newborn, your doctor will use comprehensive genetic testing to rule out “look-alike” conditions:
- Transient Neonatal Diabetes (6q24): This is the most common cause of transient (temporary) neonatal diabetes. Unlike DEND, these babies are often born very small for their gestational age. The diabetes in these cases usually goes into remission by 18 months, though it may return later in life [11][12].
- Isolated Permanent Neonatal Diabetes (PNDM): Some children have mutations in the exact same genes as DEND (like KCNJ11 or ABCC8) or the INS gene, but the effect is largely limited to the pancreas [13][14]. They have permanent diabetes without the severe neurological symptoms.
- Other Rare Syndromes: Conditions like Wolcott-Rallison syndrome or IPEX syndrome can also cause neonatal diabetes alongside other systemic issues [1][15].
A Note on Testing: Because a standard genetic sequencing panel alone may miss 6q24 methylation abnormalities or copy-number mechanisms, testing must be a specialist-directed combination of sequencing and appropriate methylation/copy-number analysis to ensure an accurate diagnosis [1][16].
Common questions in this guide
What are the first signs of DEND syndrome in a baby?
How are classic DEND syndrome and iDEND different?
Could my baby's neonatal diabetes go away?
Can seizures in DEND syndrome look like staring or repetitive movements?
What testing distinguishes DEND syndrome from other causes of neonatal diabetes?
What other conditions can resemble DEND syndrome?
What should I do if my child has low muscle tone or delayed milestones?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Look-alike conditions
Could my child's diabetes be a look-alike condition like transient neonatal diabetes?
Watching for seizures
What seizure signs should I watch for, such as staring spells?
DEND and iDEND
What is the difference between DEND and iDEND?
Get notified when new evidence is published on DEND syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study.
De Franco E, Flanagan SE, Houghton JA, et al.
Lancet (London, England) 2015; (386(9997)):957-63.
PMID: 26231457 - 2
Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation.
Barash G, Bassan H, Livne A, et al.
Acta diabetologica 2021; (58(12)):1665-1672 doi:10.1007/s00592-021-01763-1.
PMID: 34272607 - 3
Compound heterozygous variants of the NARS2 gene in siblings with developmental delay, epilepsy, and neonatal diabetes syndrome.
Yagasaki H, Sano F, Narusawa H, et al.
American journal of medical genetics. Part A 2022; (188(8)):2466-2471 doi:10.1002/ajmg.a.62873.
PMID: 35703918 - 4
DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.
Cho JH, Kang E, Lee BH, et al.
Journal of Korean medical science 2017; (32(6)):1042-1045 doi:10.3346/jkms.2017.32.6.1042.
PMID: 28480665 - 5
Case Report: When genetic diagnosis comes late: lessons from a DEND syndrome patient successfully transitioned to sulfonylurea.
Abreu GM, Bastos de Souza R, Bernardo MC, et al.
Frontiers in clinical diabetes and healthcare 2025; (6()):1654037 doi:10.3389/fcdhc.2025.1654037.
PMID: 41169283 - 6
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Beltrand J, Elie C, Busiah K, et al.
Diabetes care 2015; (38(11)):2033-41 doi:10.2337/dc15-0837.
PMID: 26438614 - 7
Permanent Neonatal Diabetes (DEND Syndrome).
Khan SA, Parkash A, Ibrahim M
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2016; (26(11)):114-115 doi:218.
PMID: 28666500 - 8
Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.
Ozsu E, Giri D, Seymen Karabulut G, Senniappan S
Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(12)):1403-1406.
PMID: 27849623 - 9
Case report: Neonatal diabetes mellitus caused by KCNJ11 mutation presenting with intracranial hemorrhage.
Wu B, Xu W
Frontiers in neurology 2023; (14()):1072078 doi:10.3389/fneur.2023.1072078.
PMID: 36937531 - 10
First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.
Ioacara S, Flanagan S, Fröhlich-Reiterer E, et al.
Journal of diabetes investigation 2017; (8(5)):716-719 doi:10.1111/jdi.12620.
PMID: 28083968 - 11
Chromosome 6q24-related diabetes mellitus.
Yorifuji T, Higuchi S, Hosokawa Y, Kawakita R
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2018; (27(2)):59-65 doi:10.1297/cpe.27.59.
PMID: 29662264 - 12
Clinical Characteristics and Remission Monitoring of 6q24-Related Transient Neonatal Diabetes.
McCullough ME, Letourneau-Freiberg LR, Bowden TL, et al.
Pediatric diabetes 2024; (2024()):3624339 doi:10.1155/pedi/3624339.
PMID: 40302951 - 13
Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.
Hashimoto Y, Dateki S, Hirose M, et al.
Pediatric diabetes 2017; (18(7)):532-539 doi:10.1111/pedi.12447.
PMID: 27681997 - 14
Identification of insulin gene variants in patients with neonatal diabetes in the Chinese population.
Fu J, Wang T, Li M, Xiao X
Journal of diabetes investigation 2020; (11(3)):578-584 doi:10.1111/jdi.13156.
PMID: 31605659 - 15
The Changing Landscape of Neonatal Diabetes Mellitus in Italy Between 2003 and 2022.
Rapini N, Delvecchio M, Mucciolo M, et al.
The Journal of clinical endocrinology and metabolism 2024; (109(9)):2349-2357 doi:10.1210/clinem/dgae095.
PMID: 38408297 - 16
Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach.
Alkorta-Aranburu G, Sukhanova M, Carmody D, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(5)):523-31.
PMID: 26894574
This page is for informational purposes only and does not constitute medical advice. It explains DEND syndrome symptoms and testing, but your child's pediatric neurology, genetics, and diabetes team should interpret their specific signs and results.